Mark Worthington

Insider Reports History

Entity
Individual
Location
C/O Athira Pharma, Inc., 18706 North Creek Parkway, Suite 104, Bothell, WA
Signature
/s/ Mark Worthington
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Worthington:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Athira Pharma, Inc. General Counsel and CCO Restricted Stock Units 110K $62.3K $0.57 Oct 1, 2024 Direct
Athira Pharma, Inc. General Counsel and CCO Common Stock 51.9K $29.4K $0.57 Sep 5, 2024 Direct
Athira Pharma, Inc. General Counsel and CCO Stock Option (Right to Buy) 110K Oct 1, 2024 Direct

Insider Reports Filed by Mark Worthington

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATHA Athira Pharma, Inc. Oct 1, 2024 2 $0 4 Oct 3, 2024 General Counsel and CCO
ATHA Athira Pharma, Inc. Sep 3, 2024 3 $12K 4 Sep 5, 2024 GENERAL COUNSEL
ATHA Athira Pharma, Inc. Feb 14, 2024 1 $0 4 Feb 16, 2024 GENERAL COUNSEL
ATHA Athira Pharma, Inc. Jan 4, 2024 3 $11.7K 4/A Feb 16, 2024 GENERAL COUNSEL
ATHA Athira Pharma, Inc. Jan 4, 2024 3 $11.7K 4 Jan 8, 2024 General Counsel
ATHA Athira Pharma, Inc. Jan 19, 2023 1 $0 4 Jan 23, 2023 General Counsel
ATHA Athira Pharma, Inc. Jun 22, 2022 3 $16.9K 4 Jun 24, 2022 General Counsel
ATHA Athira Pharma, Inc. Jan 18, 2022 1 $0 4 Jan 20, 2022 General Counsel
ATHA Athira Pharma, Inc. Nov 3, 2021 1 $0 4 Nov 5, 2021 General Counsel
ATHA Athira Pharma, Inc. Jun 1, 2021 0 $0 3 Jun 1, 2021 General Counsel